Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Why Quest (DGX) Stock Is Up Today

July 22, 2025 at 11:56 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

DGX Cover Image

What Happened?

Shares of healthcare diagnostics company Quest Diagnostics (NYSE: DGX) jumped 6.4% in the morning session after the company reported strong second-quarter financial results that beat Wall Street expectations and raised its full-year guidance.

The medical laboratory operator announced second-quarter revenues of $2.76 billion, a 15.2% increase from the same period last year. This figure surpassed analysts' forecasts of $2.72 billion. Earnings also came in ahead of expectations, with adjusted earnings per share (EPS) of $2.62, beating the average analyst estimate of $2.57. The strong performance was driven by a 16.3% increase in testing volume, which included a 2.1% rise in organic volume, indicating solid underlying demand for its services. The company also highlighted growth from acquisitions and expanded business from enterprise accounts. Buoyed by these results, Quest Diagnostics raised its full-year 2025 forecast. It now expected revenues to be between $10.80 billion and $10.92 billion, and adjusted EPS to be in the range of $9.63 to $9.83.

Is now the time to buy Quest? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Quest’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

Quest is up 16.3% since the beginning of the year, and at $175.54 per share, it is trading close to its 52-week high of $182.07 from June 2025. Investors who bought $1,000 worth of Quest’s shares 5 years ago would now be looking at an investment worth $1,353.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol

Price

Change (%)

AMZN

266.32

+0.00 (0.00%)

AAPL

308.82

+0.00 (0.00%)

AMD

467.51

+0.00 (0.00%)

BAC

51.80

+0.00 (0.00%)

GOOG

379.38

+0.00 (0.00%)

Get intelligentvalue.com

intelligentvalue.com

Safe & Secure

Fast Transfer

Flexible Payments

Why Quest (DGX) Stock Is Up Today

What Happened?

What Is The Market Telling Us

More News

Recent Quotes